Related Experiment Video
Updated: Oct 17, 2025

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease
Ophélie Fourdinier1, Griet Glorieux2, Benjamin Brigant3
1Nephrology Dialysis and Transplantation Department, Amiens University Hospital, 80054 Amiens, France.
Insights
In chronic kidney disease (CKD), miR-126 levels correlate with endothelial dysfunction and uremic toxins. This finding offers new insights into CKD
Area of Science:
- Nephrology
- Cardiovascular Research
- Molecular Biology
Background:
- Chronic kidney disease (CKD) is a significant global health issue linked to high mortality.
- Endothelial dysfunction and the accumulation of uremic toxins are key features of CKD.
- Reduced miR-126 levels are observed in CKD patients, suggesting its role in disease pathology.
Purpose of the Study:
- To investigate the relationship between miR-126 levels and markers of endothelial dysfunction in CKD patients.
- To explore the association between miR-126 and key uremic toxins across all stages of CKD.
- To elucidate the physiopathology of CKD by correlating miR-126 with specific biomarkers.
Main Methods:
- Analysis of miR-126 levels in a large cohort of CKD patients.
- Correlation studies using univariate and multivariate analyses.
- Assessment of endothelial dysfunction markers and representative uremic toxins (e.g., indoxyl sulfate, p-cresyl glucuronide).
Main Results:
- A significant correlation was found between estimated glomerular filtration rate (eGFR) and most evaluated endothelial dysfunction markers.
- miR-126 was associated with all tested uremic toxins, unlike the control cel-miR-39.
- Multivariate analysis confirmed the correlation between miR-126 and the endothelial dysfunction biomarker Syndecan-1, free indoxyl sulfate, and total p-cresyl glucuronide.
Conclusions:
- miR-126 levels are significantly associated with endothelial dysfunction and uremic toxin accumulation in CKD.
- These findings highlight the potential role of miR-126 in CKD pathophysiology.
- Further research is warranted to evaluate the role of these correlated parameters in the reduced endothelial glycocalyx (eGC) observed in CKD.
Abstract:
Chronic kidney disease (CKD) is a major cause of death worldwide and is associated with a high risk for cardiovascular and all-cause mortality. In CKD, endothelial dysfunction occurs and uremic toxins accumulate in the blood. miR-126 is a regulator of endothelial dysfunction and its blood level is decreased in CKD patients. In order to obtain a better understanding of the physiopathology of the disease, we correlated the levels of miR-126 with several markers of endothelial dysfunction, as well as the representative uremic toxins, in a large cohort of CKD patients at all stages of the disease. Using a univariate analysis, we found a correlation between eGFR and most markers of endothelial dysfunction markers evaluated in this study. An association of miR-126 with all the evaluated uremic toxins was also found, while uremic toxins were not associated with the internal control, specifically cel-miR-39. The correlation between the expression of endothelial dysfunction biomarker Syndecan-1, free indoxyl sulfate, and total p-cresyl glucuronide on one side, and miR-126 on the other side was confirmed using multivariate analysis. As CKD is associated with reduced endothelial glycocalyx (eGC), our results justify further evaluation of the role of correlated parameters in the pathophysiology of CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury II: Pathophysiology

